Bausch Health Companies Q1 Sales $2.153 Miss $2.156B Estimate
Portfolio Pulse from Benzinga Newsdesk
Bausch Health Companies (NYSE:BHC) reported Q1 sales of $2.153 billion, slightly missing the consensus estimate of $2.156 billion. This represents a significant increase from $1.944 billion in sales reported in the same period last year.
May 02, 2024 | 11:10 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bausch Health Companies reported a slight miss in Q1 sales against estimates but showed significant year-over-year growth.
The slight miss in sales estimates is unlikely to have a significant negative impact on BHC's stock price in the short term, given the substantial year-over-year growth. The growth indicates underlying strength in the company's operations, which could offset the negative sentiment from not meeting analyst expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100